Home

Chas McKhann

CIK 1631746 · Chief Executive Officer · last filed 2026-06-22

Chas McKhann is a Chief Executive Officer who has filed 13 SEC Form 4 insider transactions across 5 companies since 2015. The most recent filing, for XGN, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

13

Lifetime Open-Market Net

-$1.01M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XGN Director — $4.52 — $0 1 2026-06-22
COCHW Director — $0.03 — $0 1 2026-04-17
Silk Road Medical Inc (SILK) Delisted Chief Executive Officer 1,299,042 $27.49 $35.71M $0 3 2024-09-18
Apollo Endosurgery, Inc. (APEN) Delisted President and CEO 0 $10.00 $0 -$1.01M 6 2023-04-04
Intersect ENT, Inc. (XENT) Delisted Chief Commercial Officer — $28.24 — $0 2 2016-01-20

Recent Filings

13 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 XGN Grant (A) — $0 EDGAR
2026-04-17 COCHW Grant (A) — $0 EDGAR
2024-09-18 Silk Road Medical Inc (SILK) Delisted Mixed −722,396 $0 EDGAR
2024-03-05 Silk Road Medical Inc (SILK) Delisted Grant (A) +110,313 $0 EDGAR
2023-11-03 Silk Road Medical Inc (SILK) Delisted Grant (A) +612,083 $0 EDGAR
2023-04-04 Apollo Endosurgery, Inc. (APEN) Delisted Disp (D) −689,880 $0 EDGAR
2022-06-16 Apollo Endosurgery, Inc. (APEN) Delisted Grant (A) +112,607 $0 EDGAR
2022-05-09 Apollo Endosurgery, Inc. (APEN) Delisted Tax (F) −66,553 -$360.7K EDGAR
2021-08-20 Apollo Endosurgery, Inc. (APEN) Delisted Sell (S) −63,452 -$504.2K EDGAR
2021-08-20 Apollo Endosurgery, Inc. (APEN) Delisted Sell (S) −63,452 -$504.2K EDGAR
Showing 1–10 of 13
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.